AI IntelligenceMar 29, 2026AI Intelligence
Article
Eli Lilly signs a multi-billion dollar deal with AI drug developer Insilico Medicine.
The $2.75 billion partnership shows the pharmaceutical industry's high expectations for AI-driven drug discovery. AI aims to accelerate the lengthy and expensive development process.
Data Cube AI EditorialSource: The Decoder
01
Source Brief
Eli Lilly signs a multi-billion dollar deal with AI drug developer Insilico Medicine. The $2.75 billion partnership shows the pharmaceutical industry's high expectations for AI-driven drug discovery. AI aims to accelerate the lengthy and expensive development process.
02